A Novel Anti-Viral Antibody Cocktail therapy by REGENERON
An antibody cocktail therapy designed to prevent and treat COVID-19 is now entering Phase III clinical trials.Body generates Y-shaped molecules called antibodies that latch on to the virus and mark…
